Patents/Assignees

Cue Biopharma, Inc.

22 patents in portfolio

US12528850utility2026
Tgf-β Polypeptides
0 cites
US12485183utility2025
Multimeric T-cell Modulatory Polypeptides and Methods of Use Thereof
0 cites
US12485184utility2025
Multimeric T-cell Modulatory Polypeptides and Methods of Use Thereof
0 cites
US12421287utility2025
T-cell Modulatory Multimeric Polypeptides and Methods of Use Thereof
0 cites
US12257311utility2025
Multimeric T-cell Modulatory Polypeptides and Methods of Use Thereof
0 cites
US12180258utility2024
T-cell Modulatory Multimeric Polypeptides and Methods of Use Thereof
0 cites
US12152061utility2024
T-cell Modulatory Multimeric Polypeptides and Methods of Use Thereof
0 cites
US12145973utility2024
T-cell Modulatory Multimeric Polypeptides and Methods of Use Thereof
0 cites
US12029782utility2024
MHC Class II T-cell Modulatory Multimeric Polypeptides for Treating Type 1 Diabetes Mellitus (T1D) and Methods of Use Thereof
0 cites
US12006348utility2024
T-cell Modulatory Multimeric Polypeptide with Conjugation Sites and Methods of Use Thereof
0 cites
US11993641utility2024
Methods for Modulating an Immune Response
0 cites
US11987610utility2024
T-cell Modulatory Multimeric Polypeptides and Methods of Use Thereof
0 cites
US11958893utility2024
Methods for Modulating an Immune Response
0 cites
US11905320utility2024
T-cell Modulatory Multimeric Polypeptides and Methods of Use Thereof
0 cites
US11878062utility2024
Multimeric T-cell Modulatory Polypeptides and Methods of Use Thereof
0 cites
US11851467utility2023
T-cell Modulatory Multimeric Polypeptides and Methods of Use Thereof
0 cites
US11851471utility2023
T-cell Modulatory Multimeric Polypeptides and Methods of Use Thereof
0 cites
US11767355utility2023
Methods for Modulating an Immune Response
0 cites
US11739133utility2023
T-cell Modulatory Multimeric Polypeptides and Methods of Use Thereof
0 cites
US11708400utility2023
T-cell Modulatory Multimeric Polypeptides and Methods of Use Thereof
0 cites

Page 1 of 2Next →